SmithM.C., DanviriyasupK., CrowJ.W., CatoA.E., ParkG.D., HassidA., DunnM.J.: Prostacyclin substitution for heparin in long-term hemodialysis. Am J.Med.,73, 669, 1982.
2.
ZusmanR.M., RubinR.H., CatoA.E., CocchettoD.M., CrowJ.W., Tolkoff-RubinI.N.: Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.N. Engl. J. Med.,304, 934, 1981.
3.
YlikorkalaO., HuttunenK., JärviJ., ViinikkaL.: Prostacyclin and thromboxane in choronic uremia: effect of hemodialysis.Clin. Nephrol.,18, 83, 1982.
4.
LeithnerC., SinzingerH., StummvollH.K., KleinK., SilberbauerK., PeskarB.A.: Enhanced 6-oxo-PGF1α levels in plasma during hemodialysis.Prostaglandins and Medicine,5, 425, 1980.
5.
LeslieB.R., TerragnoA., TerragnoN.A., BlumbergA.L.: Pressor effects of indomethacin in two anephric patients with chronic hypotension.Clin. Nephrol.,18, 50, 1982.
6.
LindsayR.M., PrenticeC.R.M., DavidsonJ.G., BurtonJ.A., McNicholG.P.: Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes.Br. Med. J.,4, 454, 1972.
7.
KjellstrandC.-M., BuselmeierT.J.: A simple method for anticoagulation during pre-and postoperative hemodialysis, avoidong rebound phenomenon.Surgery,72, 630, 1972.
8.
SzczeklikJ., SzczeklikA., NizankowskiR.: Haemodynamic changes induced by prostacyclin in man.Br. Heart J., 44, 254, 1980.
9.
McGiffJ.C.: Prostaglandins, prostacyclin, and thromboxanes.Ann. Rev. Pharmacol. Toxicol.,21, 479, 1981.
10.
RitterJ.M., BarrowS.E., BlairI.A., DolleryC.T.: Release of prostacyclin in vivo and its role in man.Lancet,1, 317, 1983.
